1. Expression-based drug screening of neural progenitor cells from individuals with schizophrenia. Issue 1 (December 2018) Authors: Readhead, Benjamin; Hartley, Brigham; Eastwood, Brian; Collier, David; Evans, David; Farias, Richard; He, Ching; Hoffman, Gabriel; Sklar, Pamela; Dudley, Joel; Schadt, Eric; Savić, Radoslav; Brennand, Kristen Journal: Nature communications Issue: Volume 9:Issue 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Author Correction: Expression-based drug screening of neural progenitor cells from individuals with schizophrenia. Issue 1 (December 2018) Authors: Readhead, Benjamin; Hartley, Brigham; Eastwood, Brian; Collier, David; Evans, David; Farias, Richard; He, Ching; Hoffman, Gabriel; Sklar, Pamela; Dudley, Joel; Schadt, Eric; Savić, Radoslav; Brennand, Kristen Journal: Nature communications Issue: Volume 9:Issue 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P4‐495: SINGLE NUCLEI AND SINGLE WHOLE CELL SEQUENCING OF ALZHEIMER'S DISEASE. (1st July 2019) Authors: Enriquez, Daniel; Elyaderani, Amir; Antone, Jerry; Geiger, Philipp; Adkins, Jonathan; Serrano, Geidy E.; Mastroeni, Diego f; Beach, Thomas G.; Readhead, Benjamin; Dudley, Joel; Reiman, Eric M.; Liang, Winnie Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7(2019)Part 29 Page Start: P1503 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Longitudinal data in peripheral blood confirms PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicates its dynamic role in disease progression: Genetics/genetic factors of Alzheimer's disease. (7th December 2020) Authors: Wang, Qi; Chen, Yinghua; Readhead, Benjamin; Chen, Kewei; Su, Yi; Reiman, Eric M.; Dudley, Joel Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 3 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Deep learning‐based identification of transcriptomic signatures associated with Alzheimer's disease progression. (December 2021) Authors: Wang, Qi; Readhead, Benjamin; Chen, Kewei; Su, Yi; Reiman, Eric M.; Dudley, Joel Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 3 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. BCI‐838, an orally active mGluR2/3 antagonist pro‐drug, mimics the beneficial effects of physical exercise on neurogenesis, behavior and exercise‐related molecular pathways in an Alzheimer's disease mouse model. (20th December 2022) Authors: Bicak, Mesude; Perez‐Garcia, Georgina E.; Buros, Jacqueline; Haure‐Mirande, Jean‐Vianney; Perez, Gissel E.; Otero‐Pagan, Alena; Gama‐Sosa, Miguel E.; DeGasperi, Rita E.; Sano, Mary; Gage, Fred H.; Barlow, Carrolee; Dudley, Joel; Glicksberg, Benjamin S.; Wang, Yanzhuang; Readhead, Benjamin; Ehrlic... Journal: Alzheimer's & dementia Issue: Volume 18(2022)Supplement 10 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Deep learning‐based identification of transcriptomic signatures associated with Alzheimer's disease progression. (1st February 2022) Authors: Wang, Qi; Readhead, Benjamin; Chen, Kewei; Su, Yi; Reiman, Eric M.; Dudley, Joel Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 3 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Deep learning-based brain transcriptomic signatures associated with the neuropathological and clinical severity of Alzheimer's disease. Issue 1 (14th December 2021) Authors: Wang, Qi; Chen, Kewei; Su, Yi; Reiman, Eric M.; Dudley, Joel T.; Readhead, Benjamin Journal: Brain communications Issue: Volume 4:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPTP301S mouse model of tauopathy. (16th February 2023) Authors: Perez-Garcia, Georgina; Bicak, Mesude; Haure-Mirande, Jean-Vianney; Perez, Gissel M.; Otero-Pagan, Alena; Gama Sosa, Miguel A.; De Gasperi, Rita; Sano, Mary; Barlow, Carrolee; Gage, Fred H.; Readhead, Benjamin; Ehrlich, Michelle E.; Gandy, Sam; Elder, Gregory A. Journal: Neuroscience letters Issue: Volume 797(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗